Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma. | Front Oncol | 2023 | 36798829 | PubTator, text mining | PubMed |
| γδ T cells and their clinical application in colon cancer. | Front Immunol | 2023 | 36793708 | PubTator, text mining | PubMed |
| Microgravity and immune cells. | J R Soc Interface | 2023 | 36789512 | PubTator, text mining | PubMed |
| CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. | Cancer Cell | 2023 | 36787696 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development. | Clin Transl Oncol | 2023 | 36781600 | PubTator, text mining | PubMed |
| Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer. | Front Genet | 2023 | 36777734 | PubTator, text mining | PubMed |
| Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer. | Front Genet | 2023 | 36777726 | PubTator, text mining | PubMed |
| Multi-omics characterization of silent and productive HPV integration in cervical cancer. | Cell Genom | 2023 | 36777180 | PubTator, text mining | PubMed |
| Natural Killer Cell-Based Immunotherapy against Glioblastoma. | Int J Mol Sci | 2023 | 36768432 | PubTator, text mining | PubMed |
| The Immunology of DLBCL. | Cancers (Basel) | 2023 | 36765793 | PubTator, text mining | PubMed |
| Non-Conventional Allogeneic Anti-BCMA Chimeric Antigen Receptor-Based Immune Cell Therapies for Multiple Myeloma Treatment. | Cancers (Basel) | 2023 | 36765526 | PubTator, text mining | PubMed |
| Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. | Expert Opin Investig Drugs | 2023 | 36762937 | PubTator, text mining | PubMed |
| EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 36760869 | PubTator, text mining | PubMed |
| Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan-Cancer Analysis. | Biomed Res Int | 2023 | 36760475 | PubTator, text mining | PubMed |
| Thirdhand Smoke May Promote Lung Adenocarcinoma Development through HN1. | Comput Math Methods Med | 2023 | 36756386 | PubTator, text mining | PubMed |
| Shared sex hormone metabolism-related gene prognostic index between breast and endometrial cancers. | Front Endocrinol (Lausanne) | 2023 | 36742386 | PubTator, text mining | PubMed |
| Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy. | ESMO Open | 2023 | 36731326 | PubTator, text mining | PubMed |
| Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses. | Cell Mol Life Sci | 2023 | 36729271 | PubTator, text mining | PubMed |
| The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. | MAbs | 2023 | 36727218 | PubTator, text mining | PubMed |
| Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking. | EMBO Mol Med | 2023 | 36722664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=29